DAVID JOSEPH JOHNSON, M.D.
Osteopathic Medicine in Owensboro, KY
License number
Kentucky 37125
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
3346 Professional Park Dr, Owensboro, KY 42303
Phone
(270) 685-1066
(270) 685-0881 (Fax)
(270) 685-0881 (Fax)
Personal information
See more information about DAVID JOSEPH JOHNSON at radaris.comName
Address
Phone
Mount Sterling, KY
Whitesville, KY
Buffalo, KY
Franklin, KY
Louisville, KY
Professional information
Dr. David J Johnson, Owensboro KY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
1000 Breckenridge St, Owensboro 42303
(270) 685-1066 (Phone)
(270) 685-1066 (Phone)
Certifications:
Internal Medicine, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1000 Breckenridge St, Owensboro 42303
Owensboro Health Regional Hospital
1201 Pleasant Valley Rd, Owensboro 42303
Owensboro Health Regional Hospital
1201 Pleasant Valley Rd, Owensboro 42303
Education:
Medical School
University Of Kentucky College Of Medicine
Graduated: 1998
University Of Kentucky College Of Medicine
Graduated: 1998
David Joseph Johnson, Owensboro KY
Specialties:
Internist
Address:
1000 Breckenridge St, Owensboro, KY 42303
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
David A Johnson, Owensboro KY
Specialties:
Psychiatrist
Address:
1100 Walnut St, Owensboro, KY 42301
Method For Producing Flavored Particulate Solid Dispersions
US Patent:
2009030, Dec 10, 2009
Filed:
Oct 31, 2008
Appl. No.:
12/290575
Inventors:
David R. Worthen - Lexington KY, US
David Johnson - Owensboro KY, US
Patrick P. DeLuca - Lexington KY, US
Paolo Blasl - Belmonte Picano, IT
David Johnson - Owensboro KY, US
Patrick P. DeLuca - Lexington KY, US
Paolo Blasl - Belmonte Picano, IT
International Classification:
A24B 15/00
US Classification:
131274
Abstract:
A method for producing flavoring materials consisting of a flavor and a simple matrix material that are GRAS or approved for use in food, and that will be stable under extremely adverse conditions, greater than 50% moisture, high pH, high temperature stability (60° C.), yet be released in the oral cavity; without the use of organic solvents, and with the use of inexpensive materials and unsophisticated equipment.
Fast Dissolving Films And Coatings For Controlled Release Of Flavors, Active Pharmaceutical Ingredients, Food Substances, And Nicotine
US Patent:
2009025, Oct 8, 2009
Filed:
Dec 4, 2008
Appl. No.:
12/315603
Inventors:
Francesca Selmin - Milan, IT
Paolo Blasi - Belmonte Piceno, IT
David R. Worthen - Lexington KY, US
David Johnson - Owensboro KY, US
Patrick P. DeLuca - Lexington KY, US
Paolo Blasi - Belmonte Piceno, IT
David R. Worthen - Lexington KY, US
David Johnson - Owensboro KY, US
Patrick P. DeLuca - Lexington KY, US
International Classification:
A61K 31/44, A24B 15/36, B05D 3/02, A61K 47/30, A61P 43/00, C08L 1/00, C08L 1/26, A23L 1/226
US Classification:
514343, 131277, 427384, 514777, 10616301, 1061721, 426650
Abstract:
A fast-dissolving film for use as a platform for the delivery of material to the oral cavity, comprising a film forming agent; a plasticizing agent; and a fast-dissolving, water-soluble agent; and methods for producing same.
Tobacco-Specific Nitrosamine Detection Assays And Reagents
US Patent:
2005004, Feb 24, 2005
Filed:
May 28, 2004
Appl. No.:
10/857165
Inventors:
Michael Brown - North East MD, US
Dale Onisk - Bear DE, US
James Stave - Bear DE, US
Yichun Xu - Newark DE, US
David Johnson - Owensboro KY, US
Charles Melander - Owensboro KY, US
Dale Onisk - Bear DE, US
James Stave - Bear DE, US
Yichun Xu - Newark DE, US
David Johnson - Owensboro KY, US
Charles Melander - Owensboro KY, US
International Classification:
C12Q001/68, C07K016/00
US Classification:
530387100
Abstract:
Haptens, ligands (including antibodies), immunoassays, and test kits for detecting tobacco-specific nitrosamines (TSNAs) in samples such as tobacco products are provided. The hapten is a molecule that contains one or more structural characteristics of one or more TSNAs, and is bound to an immunogenic carrier. An antibody specific for one or more TSNAs is produced by immunizing an animal with the hapten bound to the carrier. Immunoassays and test kits using those antibodies are also provided.